Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
13.64
-0.20 (-1.45%)
Apr 29, 2026, 10:04 AM EDT - Market open
Trevi Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,912 | 1,605 | 368 | 86 | 116 | 20 | |
| Market Cap Growth | 255.71% | 336.04% | 330.28% | -26.01% | 472.04% | -54.55% | |
| Enterprise Value | 1,753 | 1,411 | 304 | -2 | 1 | 6 | |
| Last Close Price | 13.84 | 12.52 | 4.12 | 1.34 | 1.93 | 0.78 | |
| PB Ratio | 9.69 | 8.76 | 3.70 | 1.04 | 1.08 | 1.18 | |
| P/TBV Ratio | 10.59 | 8.76 | 3.70 | 1.04 | 1.08 | 1.18 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.09 | 0.86 | |
| Net Debt / Equity Ratio | -1.02 | -1.02 | -1.07 | -0.99 | -1.04 | -1.29 | |
| Net Debt / EBITDA Ratio | 3.81 | 3.81 | 2.08 | 2.42 | 3.73 | 0.68 | |
| Net Debt / FCF Ratio | 4.45 | 4.45 | 2.78 | 2.56 | 3.93 | 0.76 | |
| Quick Ratio | 19.41 | 19.41 | 10.29 | 14.33 | 8.99 | 2.90 | |
| Current Ratio | 19.66 | 19.66 | 10.41 | 15.03 | 9.15 | 2.98 | |
| Return on Equity (ROE) | -30.23% | -30.23% | -52.59% | -30.59% | -46.82% | -153.03% | |
| Return on Assets (ROA) | -20.26% | -20.26% | -32.15% | -19.96% | -23.15% | -47.42% | |
| Return on Capital Employed (ROCE) | -26.90% | -26.90% | -51.30% | -40.60% | -27.30% | -126.10% | |
| Earnings Yield | -2.20% | -2.66% | -13.01% | -33.97% | -25.21% | -167.88% | |
| FCF Yield | -2.17% | -2.62% | -10.40% | -37.22% | -24.50% | -143.18% | |
| Buyback Yield / Dilution | -32.14% | -32.14% | -2.97% | -53.44% | -182.56% | -26.48% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.